Exencial Wealth Advisors LLC Buys 928 Shares of SPDR S&P Biotech ETF (XBI)

Exencial Wealth Advisors LLC increased its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 6.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,862 shares of the exchange traded fund’s stock after purchasing an additional 928 shares during the quarter. Exencial Wealth Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $1,425,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently bought and sold shares of the stock. Natixis grew its holdings in SPDR S&P Biotech ETF by 5.5% in the 2nd quarter. Natixis now owns 49,498 shares of the exchange traded fund’s stock valued at $4,712,000 after buying an additional 2,594 shares during the period. Howard Capital Management grew its holdings in SPDR S&P Biotech ETF by 2.5% in the 3rd quarter. Howard Capital Management now owns 154,827 shares of the exchange traded fund’s stock valued at $14,843,000 after buying an additional 3,780 shares during the period. Palo Capital Inc. purchased a new stake in SPDR S&P Biotech ETF in the 2nd quarter valued at about $4,086,000. Leonetti & Associates LLC grew its holdings in SPDR S&P Biotech ETF by 40.5% in the 2nd quarter. Leonetti & Associates LLC now owns 139,225 shares of the exchange traded fund’s stock valued at $13,253,000 after buying an additional 40,150 shares during the period. Finally, WealthPLAN Partners LLC grew its holdings in SPDR S&P Biotech ETF by 4.9% in the 2nd quarter. WealthPLAN Partners LLC now owns 12,049 shares of the exchange traded fund’s stock valued at $1,147,000 after buying an additional 560 shares during the period.

XBI opened at $83.51 on Tuesday. SPDR S&P Biotech ETF has a 12 month low of $76.37 and a 12 month high of $101.55.

WARNING: This report was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this report on another domain, it was illegally copied and reposted in violation of US & international trademark & copyright legislation. The legal version of this report can be accessed at https://www.dispatchtribunal.com/2018/11/06/exencial-wealth-advisors-llc-buys-928-shares-of-spdr-sp-biotech-etf-xbi.html.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

See Also: Market Capitalization in the Stock Market

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply